IRIS
DALLA COSTA, GLORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 811
NA - Nord America 197
AS - Asia 79
OC - Oceania 1
Totale 1.088
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 509
SE - Svezia 211
US - Stati Uniti d'America 196
SG - Singapore 44
CN - Cina 28
IT - Italia 28
FI - Finlandia 24
IE - Irlanda 23
DE - Germania 7
GB - Regno Unito 6
IR - Iran 3
IN - India 2
AU - Australia 1
CA - Canada 1
FR - Francia 1
IL - Israele 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
Totale 1.088
Salva come PNG Salva come JPEG
Città #
Lawrence 46
Princeton 46
Shanghai 26
Dublin 23
Helsinki 22
Singapore 22
Boardman 15
Ashburn 14
Milan 13
Moscow 13
New York 10
Bergamo 3
Manchester 3
Kish 2
Lappeenranta 2
Assisi 1
Bengaluru 1
Bran 1
Cesena 1
Ferrara 1
Figtree 1
Gunzenhausen 1
Karachi 1
Mountain View 1
Pune 1
Sandston 1
Seattle 1
Secaucus 1
Tel Aviv 1
Zanjan 1
Totale 275
Salva come PNG Salva come JPEG
Nome #
Using smartphones and wearable devices to monitor behavioral changes during COVID-19 486
Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study 22
The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis 20
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 19
Fifteen years of wireless sensors for balance assessment in neurological disorders 19
LETTER RE: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study 18
High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis 18
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 18
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease 18
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. 17
Dysregulation of MS risk genes and pathways at distinct stages of disease 17
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 17
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review 17
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 17
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 16
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 16
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 16
From neuroimaging to clinical setting: What have we learned from migraine pain? 16
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 16
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 16
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 15
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 14
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 14
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 14
Digital epidemiology confirms a latitude gradient of MS in France 14
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study 14
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. 13
Parry Romberg Syndrome associated with chronic facial pain. 13
Vitamin D levels and risk of developing multiple sclerosis 13
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy 13
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 12
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 12
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective 12
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 12
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 12
Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR. 11
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 11
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 11
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis 11
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study 11
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 10
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation 10
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” 9
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection. 8
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 8
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes 7
null 1
null 1
null 1
null 1
Totale 1.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 0 0 0 16 0 0
2020/20219 0 0 0 4 3 0 1 0 0 0 1 0
2021/202264 0 0 0 30 2 3 5 4 5 0 0 15
2022/2023331 115 84 27 0 0 38 23 30 13 0 1 0
2023/2024615 0 2 29 18 19 14 5 18 1 5 6 498
2024/202572 72 0 0 0 0 0 0 0 0 0 0 0
Totale 1.127